PetVivo Holdings, Inc. (PETVW) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Minneapolis, MN, アメリカ. 現CEOは John Lai.
PETVW を有する IPO日 2021-08-11, 20 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $732.06K.
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.
